APA (7th ed.) Citation

S, A., CJ, R., DK, B., DC, M., KM, L., FP, P., . . . DM, A. (2022). HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19. Immunology, 166(1), 68. https://doi.org/10.1111/imm.13450

Chicago Style (17th ed.) Citation

S, Astbury, et al. "HLA-DR Polymorphism in SARS-CoV-2 Infection and Susceptibility to Symptomatic COVID-19." Immunology 166, no. 1 (2022): 68. https://doi.org/10.1111/imm.13450.

MLA (9th ed.) Citation

S, Astbury, et al. "HLA-DR Polymorphism in SARS-CoV-2 Infection and Susceptibility to Symptomatic COVID-19." Immunology, vol. 166, no. 1, 2022, p. 68, https://doi.org/10.1111/imm.13450.